Clinical Trial Update: TMP001 in Relapsing-remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of TMP001 in relapsing-remitting multiple sclerosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• TMP001

Snippet

Sponsor: Dr. Frank Behrens | Conditions: Remitting-Relapsing Multiple Sclerosis | Phase 2 | Status: COMPLETED